Ticker Details
Glaukos Corporation Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma.
IPO Date:	June 25, 2015
Sector:	Healthcare
Industry:	Medical Instruments and Equipment
Market Cap:	$9.11B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.34 | 2.20%
Avg Daily Range (30 D):	$3.11 | 2.51%
Avg Daily Range (90 D):	$2.70 | 2.20%

Institutional Daily Volume
Avg Daily Volume:	.49M
Avg Daily Volume (30 D):	.91M
Avg Daily Volume (90 D):	.72M

Trade Size
Avg Trade Size (Sh.):	66
Avg Trade Size (Sh.) (30 D):	48
Avg Trade Size (Sh.) (90 D):	46

Institutional Trades
Total Institutional Trades:	6,370
Avg Institutional Trade:	$3.29M
Avg Institutional Trade (30 D):	$8.57M
Avg Institutional Trade (90 D):	$8.09M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.99M
Avg Closing Trade (30 D):	$23.77M
Avg Closing Trade (90 D):	$17.11M
Avg Closing Volume:	64.41K

News

Jul 8, 2026 @ 9:03 PM Abbott Labs vs. Glaukos: Which Healthcare Stock Is... Source: Brendan Coffey

May 11, 2026 @ 5:00 PM Presbyopia Market to Witness Accelerated Growth at... Source: Delveinsight

Sep 4, 2025 @ 5:30 AM Nicox prévoit de rembourser intégralement se... Source: Nicox Sa

Sep 4, 2025 @ 5:30 AM Nicox Expects to Fully Repay Financial Debts with ... Source: Gavin Spencer

Sep 11, 2024 @ 6:20 PM Glaukos Stocks Rides on Strong Product Demand Amid... Source: Zacks

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.28	$-2.33	$-3.28
Diluted EPS	$-3.28	$-2.33	$-3.28
Revenue	$507.44M	$143.12M	$507.44M
Gross Profit	$282.76M	$-1.52M	$282.76M
Net Income / Loss	$-187.69M	$-133.66M	$-187.69M
Operating Income / Loss	$-199.6M	$-139.87M	$-199.6M
Cost of Revenue	$111.81M	$31.77M	$111.81M
Net Cash Flow	$-80.52M	$-6.62M	$-80.52M
PE Ratio